T4090

· Laboratoires Thea

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for T4090, covering 2024-02-07 to 2024-02-07. Get the full timeline:

Most recent: Clinical Trial Update: Safety Assessment of T4090 Eye Drops in Ocular Hypertensive or Glaucomatous Patients. [Phase 1, Phase 2]